Press Release: Mapmygenome Adds QR Code to COVID Reports as per Dubai Guidelines
Hyderabad, February 23, 2021: India-based genomics company Mapmygenome announced that their COVID test reports include a QR code enabling access to the original test report stored in their secure LIMS server. All reports generated at Mapmygenome laboratories have the QR code as well as information on date and time of sample collection and sample reporting. This announcement comes within days of Dubai Health Authority’s new guidelines.
Mapmygenome has two COVID testing labs – one at Rajiv Gandhi International Airport Hyderabad and one at their Corporate Headquarters. All samples collected are accessioned to their in-house Laboratory Information Management System (LIMS), Biotracker™. The entire process flow for all their tests is mapped into Biotracker™. This LIMS also has a BARCODE and QR CODE generating tool. Mapmygenome’s IT team has enabled the inclusion of QR code to all COVID reports. On scanning the QR code on the printed report, authorities can access the original report.
Mapmygenome CEO Ms. Anu Acharya said, “Dubai Health Authority’s new QR code guidelines are an assured way to ensure honesty in COVID test result reporting and we are really happy to comply. With the number of air passengers increasing, this is a good measure to track and prevent further spread of COVID. All passengers travelling via Hyderabad can take this test at the International Airport and receive QR coded test reports. Our automated workflow enabled us to implement this change with Zero downtime.”
Mapmygenome® is India’s largest personal genomics company that encourages people to be proactive about their health. Mapmygenome offers personalized health solutions based on genetic tests that help people get to understand their genetic selves. By combining genetic health profiles, health history, and genetic counselling, Mapmygenome provides actionable steps for individuals to lead healthier lives.
Founded in 2013, Mapmygenome started as India’s pioneering Personal Genomics Company with a vision to “Touch 100 million lives and save a million lives by 2030.” Mapmygenome’s teams at Hyderabad, Delhi, and Mumbai comprise biotechnologists, statisticians, geneticists, bioinformaticians, and medical counsellors. Mapmygenome has analysed thousands of samples from all over India and various countries and has provided personalized genetic reports that have been used in early detection of disease and increased quality of life.
Mapmygenome was among the first private diagnostic labs to receive approval from Telangana State Government for COVID-19 testing. Their lab analyses samples for SARS-CoV-2 from walk-in customers, healthcare partners, home collections, and corporate clients. In November 2020, they launched a new NABL and ICMR approved COVID testing lab at Hyderabad International Airport.
For more information, visit www.mapmygenome.in.
Biotracker™ is an end-to-end Laboratory Information Management System developed by Ocimum Biosolutions, the technology incubator for Mapmygenome. Biotech, life sciences, and healthcare labs across the globe use Biotracker customized to suit their laboratory needs. In addition to organized structure and data security, this adaptive platform offers a laboratory’s choice of regulatory compliance while enabling productivity. Key features of Biotracker include Laboratory Administration, Project Design and Scheduling, Work Flow and Process Tracking, Experiment Tracking, Analysis and Archival, Sample Management and Chain of Custody, Hierarchal Location Tracking, Plate Tracking, Inventory Management and Tracking, Special Inventories, Forms and Fields, Instrument Integration for Automated Data Capture, Report Builder, Cost Estimation of Projects, Invoicing, and Reports of Raw Data and Integrated Results.